key: cord-0888930-amfufk8e authors: Fayed, Islam; Pivazyan, Gnel; Conte, Anthony G.; Chang, Jason; Mai, Jeffrey C. title: Intracranial Hemorrhage in Critically Ill Patients Hospitalized for COVID-19 date: 2020-08-18 journal: J Clin Neurosci DOI: 10.1016/j.jocn.2020.08.026 sha: 0c4cb2c9b078c0759f685ca7c9c199255f4cdbc3 doc_id: 888930 cord_uid: amfufk8e In this study, we report three cases of spontaneous intracranial hemorrhage in patients who were initially hospitalized at our tertiary care center in Washington, DC with symptoms of COVID-19. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was diagnosed in all three patients, who were critically ill, requiring intubation and ventilatory support. During their protracted hospitalizations, subsequent imaging disclosed intracranial hemorrhages, including intracerebral and subarachnoid hemorrhages, in the context of anticoagulation and coagulopathy. We believe this is related to the tropism of SARS-CoV-2 to the endothelial lining of the cerebral vasculature via their angiotensin-converting enzyme (ACE) II receptors. Given our findings, we advocate heightened vigilance for intracerebral hemorrhage events, and scanning when practicable, in COVID-19 patients which have prolonged ventilatory support and depressed neurologic examinations. In this study, we report three cases of spontaneous intracranial hemorrhage in patients who were initially hospitalized at our tertiary care center in Washington, DC with symptoms of COVID-19. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was diagnosed in all three patients, who were critically ill, requiring intubation and ventilatory support. During their protracted hospitalizations, subsequent imaging disclosed intracranial hemorrhages, including intracerebral and subarachnoid hemorrhages, in the context of anticoagulation and coagulopathy. We believe this is related to the tropism of SARS-CoV-2 to the endothelial lining of the cerebral vasculature via their angiotensin-converting enzyme (ACE) II receptors. Given our findings, we advocate heightened vigilance for intracerebral hemorrhage events, and scanning when practicable, in COVID-19 patients which have prolonged ventilatory support and depressed neurologic examinations. Keywords: COVID-19, Coagulopathy, Endothelial injury, Intracerebral hemorrhage, Subarachnoid hemorrhage We report three cases of spontaneous intracranial hemorrhage in patients who were initially hospitalized at our tertiary care center in Washington, DC with symptoms of COVID-19. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was diagnosed in all three patients, who were critically ill, requiring intubation and ventilatory support. During their protracted hospitalizations, subsequent imaging disclosed intracranial hemorrhages, including intracerebral and subarachnoid hemorrhages, in the context of anticoagulation and coagulopathy. Our first patient was a 57-year-old woman with past medical history of hypertension, obesity, sleep apnea, and asthma who presented to our emergency department (ED) with shortness of breath and fever. After testing positive for SARS-CoV-2, she was initially admitted to the floor and subsequently escalated to the intensive care unit (ICU) and intubated for hypoxic respiratory failure. She developed acute renal insufficiency, requiring continuous veno-venous hemofiltration under coverage of a heparin drip. Following two weeks of mechanical ventilation, a computed tomography (CT) scan of the head was performed given persistent encephalopathy, revealing a subacute lobar right frontal intracerebral hemorrhage (ICH) ( Figure 1A) . No coagulation or platelet dyscrasias were uncovered. Repeat CT imaging was stable, and following negative PCR testing for SARS-CoV-2, she was able to undergo contrasted magnetic resonance imaging (MRI), which did not disclosed an underlying pathology for the original ICH and revealed interval development of ICH in the left frontal lobe, despite being off heparization at that time ( Figure 1B -C). Interestingly, it also revealed significant inflammation of the sphenoid sinusa putative mechanism for neuro-invasion by the virus ( Figure 1D ). The patient was subsequently discharged to an acute rehabilitation facility one week later. The second patient is a 54-year-old female with past medical history of hypertension, obesity, and bilateral mastectomy in 2016 for BRCA2 mutant breast cancer who presented to our ED with four days of myalgia and fever. After testing positive for SARS-CoV-2, she was discharged to home, but was admitted two days later with dyspnea and hypoxia necessitating She progressed to brain death and expired due to asystole four days later. The third patient is a 71-year-old gentleman with past medical history of hypertension, type II diabetes, chronic kidney disease, and B-cell lymphoma in remission who presented to the ED with acute onset shortness of breath and dizziness. After testing positive for SARS-CoV-2, the patient was admitted, progressing from a 15-liter supplement oxygen requirement to intubation, prone positioning, and vasopressor support within 5 days of admission. At two weeks postintubation, persistent encephalopathy promoted a surveillance head CT, which disclosed a right occipital ICH with surrounding edema suggestive of hemorrhagic conversion of an infarct ( Figure 1G -H). D-dimer and fibrinogen were elevated to 3.2mcg/mL (normal range 0 -0.72mcg/mL) and 1,018mg/dL (normal range 213 -536mg/dL), respectively, indicating a hypercoagulable state. While international normalized ratio (INR) and platelet counts were within normal range prior to the hemorrhage, they subsequently became profoundly hypercoagulable and thrombocytopenic afterwards, suspicious for disseminated intravascular coagulation (DIC). While the ICH remained stable on repeat imaging, the patient ultimately succumbed to multi-system organ failure one week later. These cases support the predisposition of COVID-19 patients to the development of intracranial hemorrhage during critical illness. The pathophysiology is unclear, but the tropism of SARS-CoV-2 to the endothelial lining of the cerebral vasculature via their angiotensin-converting enzyme (ACE) II receptors, remains a possibility [1] [2] , and a recent pathology study The Lancet demonstrated the presence of virus particles within endothelial cells and an accumulation of inflammatory cells, leading to endothelial cell death. [3] Furthermore, a recent Italian review of animal studies suggests a higher neuro-invasive property of SARS-CoV-2 compared to other coronaviruses. [4] Zhou et al were able to detect SARS-CoV-2 RNA in human cerebrospinal fluid, and neurologic sequelae have been observed in an estimated 36% of COVID-19 patients. [5] [6] [7] Postmortem brain studies have also shown direct invasion of neurons and glial cells. [8, 9] Several studies have suggested a pro-thrombotic state in these patients, possibly related to antiphospholipid antibodies, which may lead to ischemic complications related to occlusion of the cerebral vasculature. [10] [11] [12] [13] [14] [15] Additionally, numerous reports of ICH in COVID-19 have begun to accumulate in the literature. [16] [17] [18] [19] [20] Collectively, these findings corroborate the possibility of direct cerebrovascular endothelial injury, vascular injury, and DIC leading to cerebral hemorrhagic events, exacerbated by concomitant anticoagulation therapy in two instances. The ability to identify and treat these patients is hindered by the strict isolation and precautions mandated by COVID-19 infection. Given our findings, we advocate heightened vigilance for intracerebral hemorrhage events, and scanning when practicable, in COVID-19 patients which have prolonged ventilatory support and depressed neurologic examinations. None. This study did not require approval by our institution's Institutional Review Board and did not require patient consent due to the retrospective nature of the analysis. The authors certify that this manuscript is a unique submission and is not being considered for publication, in part or in full, with any other source in any medium. Each named author has substantially contributed to conducting the underlying research and drafting this manuscript. Additionally, to the best of our knowledge, the named authors have no conflict of interest, financial or otherwise. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options COVID-19 and intracerebral haemorrhage: causative or coincidental? Endothelial cell infection and endotheliitis in COVID-19 Does SARS-Cov-2 invade the brain? Translational lessons from animal models Explanation for COVID-19 infection neurological damage and reactivations Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review COVID-19 and Cerebral Hemorrhage: Proposed Mechanisms Neurological Involvement in COVID-19 and Potential Mechanisms: A Review Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series COVID-19 Neurologic Complication with CNS Vasculitis-Like Pattern A case of COVID-19 pneumonia with cerebral hemorrhage Hemorrhagic encephalopathy associated with COVID-19 Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series Letter: Hemorrhagic Conditions Affecting the Central Nervous System in COVID-19 Patients Pathophysiology of SARS-CoV-2 infection in patients with intracerebral hemorrhage